SoLá Pelvic Therapy is a health care startup founded in 2010, based in the United States. The company's slogan "We provide the fastest acting and most effective single medical therapy for most women with pelvic pain" exemplifies its focus on addressing a prevalent and often overlooked health issue. With one in ten women and a significant number of men suffering from chronic pelvic pain, the need for effective treatment options is evident. SoLá Pelvic Therapy distinguishes itself by offering the only medical device specifically designed to cater to this disease state. The company's approach involves Health Care Providers procuring SoLá Therapy Photobiomodulation Laser systems in a subscription model and purchasing single-use sterile probe kits for each patient. This model positions the company within the health care and manufacturing industries simultaneously, offering a unique value proposition. The proprietary SoLá Pelvic Therapy Laser user interface not only facilitates treatment but also gathers real-world patient experience data on disease states and symptoms in a HIPAA compliant system. This strategic focus on data collection and analysis can potentially provide valuable insights for both the company and the broader medical community. While specific details about the latest investment round and its investors were not available, the uniqueness of SoLá Pelvic Therapy’s product and the pressing need it addresses make it an intriguing prospect for potential investors. As the company continues to establish itself as a significant player in the health care industry, keeping an eye on its future developments and potential funding activities could prove to be a promising venture investment.
There is no investment information
No recent news or press coverage available for SoLá Pelvic Therapy.